ABOUT JOURNAL

FOCUS AND SCOPE

The journal includes various fields of pharmaceuticals sciences such as:
-Pharmacology and Toxicology
-Pharmacokinetics
-Community and Clinical Pharmacy
-Pharmaceutical Chemistry
-Pharmaceutical Biology
-Pharmaceutics
-Pharmaceutical Technology
-Biopharmaceutics
-Pharmaceutical Microbiology and Biotechnology
-Alternative medicines

OPEN ACCESS POLICY

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

PUBLICATION ETHICS

Publication Ethics and Malpractice Statement
Indonesian Journal of Pharmacy (Indonesian J. Pharm.) is an international peer-reviewed journal. This statement clarifies ethical conduct to all parties involved in manuscript publication Indonesian J. Pharm, including the author(s), Editor in Chief, the Editorial Board, the peer-reviewer, and the publisher (Faculty of Pharmacy, Gadjah Mada University). This statement is relied on Practice Guidelines for publication as in Committee on Publication Ethics (COPE’s Best).

Ethical Guideline for Journal Publication
The publication of an article in a peer-reviewed Indonesian Journal of Pharmacy is an essential building block in the development of a coherent and respected network of knowledge. It is a direct reflection of the quality of the work of the authors and the institutions that support them. Peer-reviewed articles support and embody the scientific method. It is therefore important to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editor, the peer reviewer, the publisher as well as the society.
Faculty of Pharmacy, Gadjah Mada University, Indonesia as the publisher of Indonesian Journal of Pharmacy takes its duties of guardianship over all stages of publishing extremely seriously and we recognize our ethical and other responsibilities. We are committed to ensuring that advertising, reprint or other commercial revenue has no impact or influence on editorial decisions. In addition, the Faculty of Pharmacy, Gadjah Mada University, and Editorial Board will assist in communications with other journals and/or publishers where this is useful and necessary.

Publication decisions
The editor of the Indonesian Journal of Pharmacy is responsible for deciding which of the articles submitted to the journal should be accepted for publication. The validation of the work in question and its importance to researchers and readers must always drive such decisions. The editors may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editors may confer with other editors or reviewers in making this decision. The journal used Viper Plagiarism Scanner to detect the possibilities of plagiarism in the manuscript.

Fair play
An editor at any time evaluates manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.

Confidentiality
The editor and any editorial board member must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, other editorial advisers, and the publisher, as appropriate.

Disclosure and conflicts of interest
Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author.

DUTIES OF REVIEWERS
Contribution to Editorial Decisions
Reviewer(s) assists the editorial team in making editorial decisions and through the editorial communications with the author. Besides, the reviewer(s) may also assist the author in improving the paper.

Promptness
Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.

Confidentiality
Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.

Standards of Objectivity
Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.

Acknowledgment of Sources
Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

Disclosure and Conflict of Interest
Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

DUTIES OF AUTHORS
Reporting standards
Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical conduct and are unacceptable.

Data Access and Retention
Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should, in any event, be prepared to retain such data for a reasonable time after publication.

Originality and Plagiarism
The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.

Multiple, Redundant or Concurrent Publication
An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing conduct and is unacceptable.

Acknowledgment of Sources
Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.

Authorship of the Paper
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

Hazards and Human or Animal Subjects
If the work involves chemicals, procedures, or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. The procedures related to humans or animals should be approved by the Ethics Committee and/or refer to the standard procedures.

Natural Medicine Materials
A study using natural medicine materials should provide the latin names, nomenclature author, family name (in parentheses), the source, extraction/fractionation methods for all collected materials used in the study. Pharmacological Evaluation of the materials should use a reference (positive control).

Disclosure and Conflicts of Interest
All authors should disclose in their manuscript any financial or another substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

Fundamental errors in published works
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper

 

PUBLICATION FREQUENCY

Indonesian J pharm is a quarterly journal, published in January-March, April-June, July-September, and October-December

DIGITAL ARCHIVING

This journal utilizes the Indonesia One Search (IOS), Indonesian Scientific Journal Database (ISJD), and Indonesian Publication Index (IPI) system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration.

AUTHORS FEES

Since 2018, starting from vol 29 Issue 1, the Indonesian Journal of Pharmacy has been indexed by Scopus. Therefore, to maintain quality and timely publication, any accepted manuscript for publication, which had been submitted after January 1, 2019, will be charged USD 200 per manuscript as the publication fee.